David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
XP
XP
$8.66B
| $25M | 0.02% |
1,818,273
+1,645,260
| +951% | +$22.7M |
|
752
Procept Biorobotics
PRCT
$1.22B
| $25M | 0.02% |
428,903
-178,450
| -29% | -$12.2M |
|
753
Steris
STE
$23.2B
| $25M | 0.02% |
110,111
-71,067
| -39% | -$15.6M |
|
754
Pinterest
PINS
$13.3B
| $24.9M | 0.02% |
802,048
-1,313,574
| -62% | -$44.5M |
|
755
PUT
Halliburton
HAL
$28.9B
| $24.7M | 0.02% |
973,700
-387,300
| -28% | -$10.2M |
|
756
FirstCash
FCFS
$10.3B
| $24.7M | 0.02% |
205,292
-88,989
| -30% | -$10.1M |
|
757
PUT
Dow Inc
DOW
$22.7B
| $24.6M | 0.02% |
705,400
-17,700
| -2% | -$680K |
|
|
DHC
758
Diversified Healthcare Trust
DHC
$1.94B
| $24.6M | 0.02% |
10,251,352
-729,046
| -7% | -$1.8M |
|
759
L3Harris
LHX
$48.9B
| $24.6M | 0.02% |
117,486
+110,409
| +1,560% | +$23.1M |
|
|
TEM
760
CALL
Tempus AI
TEM
$11.9B
| $24.6M | 0.02% |
+509,700
| New | +$27.5M |
|
761
Prudential Financial
PRU
$42.3B
| $24.6M | 0.02% |
219,965
+187,924
| +587% | +$21.4M |
|
762
PUT
APA Corp
APA
$15.1B
| $24.6M | 0.02% |
1,168,200
-2,100
| -0.2% | -$46.1K |
|
763
Floor & Decor
FND
$5.84B
| $24.5M | 0.02% |
304,937
-1,022,330
| -77% | -$96.6M |
|
764
Mirum Pharmaceuticals
MIRM
$5.9B
| $24.5M | 0.02% |
543,277
+385,925
| +245% | +$18.2M |
|
765
Global Payments
GPN
$25B
| $24.4M | 0.02% |
249,262
+221,612
| +801% | +$23.2M |
|
766
MarketAxess Holdings
MKTX
$5.72B
| $24.3M | 0.02% |
112,480
+98,349
| +696% | +$20.7M |
|
767
CALL
Regeneron Pharmaceuticals
REGN
$85.3B
| $24.3M | 0.02% |
38,300
-400
| -1% | -$275K |
|
768
Chubb
CB
$133B
| $24.2M | 0.02% |
80,000
+74,438
| +1,338% | +$20.7M |
|
769
Freshworks
FRSH
$3.44B
| $24.1M | 0.02% |
1,707,632
+75,683
| +5% | +$1.27M |
|
|
BRSL
770
Brightstar Lottery PLC
BRSL
$2.16B
| $24.1M | 0.02% |
1,480,507
+51,614
| +4% | +$891K |
|
771
CVS Health
CVS
$120B
| $24.1M | 0.02% |
355,105
-828,846
| -70% | -$49.6M |
|
772
AMN Healthcare
AMN
$1.34B
| $24M | 0.02% |
983,078
+726,839
| +284% | +$18.7M |
|
773
PUT
Monolithic Power Systems
MPWR
$63.2B
| $24M | 0.02% |
41,300
+12,600
| +44% | +$7.94M |
|
774
CALL
First Citizens BancShares
FCNCA
$24.7B
| $23.9M | 0.02% |
12,900
-700
| -5% | -$1.43M |
|
|
VNET
775
VNET Group
VNET
$1.84B
| $23.8M | 0.02% |
2,896,857
+1,381,456
| +91% | +$12.7M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.